Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Normative Hand Grip Strength Values in Swedish Male and Female Ice Hockey Players Across Competitive Levels

22 mei 2026 bijgewerkt door: Daniel Muder, Dalarna County Council, Sweden

This study measures hand grip strength in male and female ice hockey players across different Swedish leagues to create reference (normative) values for adult players.

Hand grip strength is a simple test of how strongly a person can squeeze with their hand. Although it seems basic, it reflects overall upper-body strength and is widely used in both sports science and healthcare.

In this project, players from different levels of ice hockey (including professional men's and women's leagues, junior players, and recreational players if available) will have their grip strength measured using a standardized hand dynamometer. Measurements will be taken in a consistent way across all participating clubs.

The main goal is to build a reference database showing what "normal" grip strength looks like in ice hockey players depending on sex, league level, and playing position. This can help coaches, medical staff, and researchers better understand strength profiles in hockey athletes, support training and rehabilitation decisions, and provide benchmarks for future studies.

No treatment or intervention is given as part of the study.

Studie Overzicht

Toestand

Nog niet aan het werven

Gedetailleerde beschrijving

This is a cross-sectional, descriptive, multi-league study designed to establish normative values for maximal isometric hand grip strength in adult Swedish ice hockey players.

Hand grip strength will be used as a standardized, low-cost proxy measure of upper-body muscular strength and general functional capacity. Although grip strength is widely used in clinical and sports science settings and has demonstrated good reliability when measured using standardized protocols, there is currently a lack of comprehensive normative data for adult ice hockey players. Existing literature is largely limited to youth cohorts or general athletic "combine"-type populations, with insufficient stratification for adult competitive ice hockey across sexes, league levels, and playing positions.

This study will include male and female players from multiple competitive levels in Swedish ice hockey, including professional leagues (SHL and SDHL), second-tier leagues (HockeyAllsvenskan and Women's Allsvenskan where feasible), junior elite levels (U18/U20), and potentially recreational adult players. Participants will be recruited through participating clubs during the pre-season or early competitive season period.

Grip strength will be measured using a standardized hand dynamometer according to a unified protocol aligned with established clinical measurement guidelines (including standardized positioning, device calibration, and repeated trials per hand). Both dominant and non-dominant hand grip strength will be recorded, and mean values will be used for analysis. To reduce inter-tester variability, participating sites will be instructed to follow a harmonized measurement protocol.

In addition to grip strength, basic demographic and anthropometric data will be collected, including age, sex, playing position (forward/defense), playing experience, height, and body mass. Where available, supplementary body composition data from club testing routines may also be included to allow exploratory analyses of strength relative to body size.

The primary purpose of the study is descriptive: to generate normative reference values (including percentiles) for grip strength in adult ice hockey players, stratified by sex, league level, and playing position. Secondary analyses will explore associations between grip strength and anthropometric and demographic variables.

This study does not include any intervention or experimental treatment. All measurements are non-invasive and performed during routine testing environments within clubs. The results are intended to support strength and conditioning practice, clinical assessment in sports medicine, and future research on performance, injury risk, and rehabilitation in ice hockey.

Studietype

Observationeel

Inschrijving (Geschat)

800

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Kind
  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Nee

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

Adult male and female ice hockey players recruited from Swedish ice hockey clubs across multiple competitive levels, including professional (SHL and SDHL), second-tier (HockeyAllsvenskan and Women's Allsvenskan where available), junior elite (U18/U20), and selected recreational teams. Participants are drawn from active club rosters during the pre-season or early competitive season period. Recruitment is conducted in collaboration with participating clubs and their medical or strength and conditioning staff. The population represents a broad sample of Swedish ice hockey players across sex, age, and competitive level.

Beschrijving

Inclusion Criteria:

  • Adult male or female ice hockey players.
  • Registered and actively participating in a Swedish ice hockey club during the current season.
  • Participation in one of the included competitive levels: professional, semi-professional, junior elite, or recreational leagues in Sweden.
  • Able to perform maximal hand grip strength testing. Provides written informed consent.

Exclusion Criteria:

  • Current acute injury of the upper extremity (hand, wrist, forearm, or elbow) that prevents safe or valid grip strength testing.
  • Any medical condition that contraindicates maximal effort testing, as determined by team medical staff or study personnel.
  • Refusal or inability to provide informed consent.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

Cohorten en interventies

Groep / Cohort
Ice Hockey Players
Adult male and female ice hockey players from multiple competitive levels in Sweden, including professional, semi-professional, junior elite, and recreational players. Participants undergo a single standardized measurement of hand grip strength.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Maximal Hand Grip Strength
Tijdsspanne: Baseline.
Maximal isometric hand grip strength measured in kilograms using a standardized hand dynamometer in adult male and female ice hockey players. Measurements will be performed for both dominant and non-dominant hands using a standardized protocol, and mean maximal value will be used for analysis.
Baseline.

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Anthropometric Characteristics
Tijdsspanne: Baseline.
Height (cm), body mass (kg), and body composition (if available) of adult male and female ice hockey players.
Baseline.
Demographic and Playing Characteristics
Tijdsspanne: Baseline.
Age, sex, playing position (forward/defense), league level, dominant hand, and years of playing experience in ice hockey.
Baseline.

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Daniel Muder, MD, PhD, Centre for Clinical Research Dalarna, Uppsala University, Sweden

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

1 september 2026

Primaire voltooiing (Geschat)

31 december 2026

Studie voltooiing (Geschat)

31 december 2026

Studieregistratiedata

Eerst ingediend

23 april 2026

Eerst ingediend dat voldeed aan de QC-criteria

30 april 2026

Eerst geplaatst (Werkelijk)

5 mei 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

27 mei 2026

Laatste update ingediend die voldeed aan QC-criteria

22 mei 2026

Laatst geverifieerd

1 mei 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • 2026-02210-01B

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

JA

Beschrijving IPD-plan

Any data shared with colleagues or collaborating researchers will be fully anonymized or pseudonymized to protect participant privacy in accordance with GDPR regulations. Data transfers will occur under strict confidentiality agreements, and all parties will adhere to applicable data protection laws to ensure the security and privacy of personal information. We will act in accordance with the ethical approval granted by the Swedish Ethical Review Authority (EPM) and comply with all relevant local policies regarding data protection.

IPD-tijdsbestek voor delen

From the publication of the protocol and for 10 years thereafter.

IPD-toegangscriteria voor delen

Access to individual participant data is typically restricted to authorized researchers involved in the study or approved collaborators under strict confidentiality and data protection agreements.

IPD delen Ondersteunend informatietype

  • LEERPROTOCOOL
  • SAP
  • ICF

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren